Market Cap 23.18B
Revenue (ttm) 5.46B
Net Income (ttm) 614.64M
EPS (ttm) N/A
PE Ratio 25.53
Forward PE 23.31
Profit Margin 11.26%
Debt to Equity Ratio 0.31
Volume 430,320
Avg Vol 646,776
Day's Range N/A - N/A
Shares Out 98.37M
Stochastic %K 11%
Beta 0.94
Analysts Strong Sell
Price Target $272.14

Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in p...

Industry: Medical Devices
Sector: Healthcare
Phone: 440 354 2600
Address:
5960 Heisley Road, Mentor, United States
NoOnions
NoOnions Jun. 23 at 6:40 PM
$TOMZ Whats funnier? ray getting stung by a bee or Iran being turned into a parking lot? BZZZZZZ, Kaboom. Lets have a win-win deal. Pour honey all over Ayatollahs nuts and the bees Steramist saves can sting him to death.And Ray makes big money. $STE $PFE $JNJ $LLY Wake up people. Steramist can save the world.Buyout coming from a big boy.
0 · Reply
DonCorleone77
DonCorleone77 Jun. 21 at 1:45 PM
$STE Steris awarded $450M Navy contract modification Steris has been awarded a maximum $450M modification exercising the five-year option period of a five-year base contract with one five-year option period for patient monitoring and capital equipment. This is a fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract. The ordering period end date is June 22, 2030. Using customers are Army, Navy, Air Force, Marines Corps, and federal civilian agencies. Type of appropriation is fiscal 2025 through 2030 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support.
0 · Reply
NoOnions
NoOnions Jun. 10 at 11:25 AM
$MMM $STE I wonder if Steramist would be a good fit in your arsenal? $TOMZ is in buyout territory. Trump should be spraying this shit all over LA. RFK sprays Steramist on his wife before he knocks that out.Dont sell until you see the $3/Sh number is what WrongRay says!
0 · Reply
d_risk
d_risk May. 30 at 12:53 AM
$STE - STERIS plc (Ireland) Ordinary Shares - 10K - Updated Risk Factors STE’s 2025 10-K risks highlight intensified economic, geopolitical, and regulatory challenges, expanded healthcare policy and reimbursement uncertainties, heightened EO sterilization litigation and regulatory scrutiny, supply chain vulnerabilities, competitive pressures, acquisition integration risks, rising compliance costs, and potential goodwill impairments—all threatening financial flexibility and operational stability. #HealthcareSector #EconomicChallenges #LitigationRisks #SupplyChain #RegulatoryRisks 🟢 Added 🟠 Removed https://d-risk.ai/STE/10-K/2025-05-29
0 · Reply
JarvisFlow
JarvisFlow May. 29 at 12:30 PM
Jefferies has updated their rating for Steris ( $STE ) to Hold with a price target of 263.
0 · Reply
CHItraders
CHItraders May. 29 at 11:14 AM
📈 INITIATIONS $ELS Equal-Weight Barclays $70 $HPQ Neutral KGI Securities $25 $PRSU Buy Stifel $38 $STE Hold Jefferies $263 $IPXXU Buy Roth Capital Partners $15
0 · Reply
ZacksResearch
ZacksResearch May. 21 at 11:24 AM
$STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment. Read the full story here: https://www.zacks.com/stock/news/2475126/is-it-the-right-time-to-hold-steris-stock-in-your-portfolio?cid=sm-stocktwits-2-2475126-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2475126_TEASER
0 · Reply
NoOnions
NoOnions May. 16 at 11:09 AM
$TOMZ Asshat thinks he knows more than institutional buyers. Stop smoking crack Ray. RFK says its bad for your health. https://fintel.io/so/us/tomz Only a matter of time before large fish scoops up this little nugget. $TSLA Even Elon sprays Steramist on his rockets ! $NVDA $STE
0 · Reply
kylehardy15
kylehardy15 May. 15 at 2:11 PM
$LUCD $BSX $MDT $STE $LH STERIS purchased truFreeze a few years back which treats esophageal cancer.
2 · Reply
Estimize
Estimize May. 15 at 10:03 AM
$STE reported 2.74 EPS and 1,481 revenue for Q4. http://www.estimize.com/intro/ste?chart=historical&metric_name=eps&utm_content=STE&utm_med
0 · Reply
Latest News on STE
STERIS plc (STE) Q4 2025 Earnings Call Transcript

May 15, 2025, 1:52 PM EDT - 5 weeks ago

STERIS plc (STE) Q4 2025 Earnings Call Transcript


Why This Medical Equipment Stock Is Today's S&P 500 Winner

May 15, 2025, 12:39 PM EDT - 5 weeks ago

Why This Medical Equipment Stock Is Today's S&P 500 Winner


STERIS Declares Dividend of $0.57 per share

May 7, 2025, 4:30 PM EDT - 6 weeks ago

STERIS Declares Dividend of $0.57 per share


10 Undervalued Dividend Growth Stocks: May 2025

May 7, 2025, 9:00 AM EDT - 6 weeks ago

10 Undervalued Dividend Growth Stocks: May 2025

AMAT ELV EOG FELE IMO INTU LRCX


Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'

Mar 22, 2025, 7:22 AM EDT - 3 months ago

Steris: AST Recovery Is Ongoing; Upgrading To 'Strong Buy'


STERIS plc (STE) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 2:52 PM EST - 4 months ago

STERIS plc (STE) Q3 2025 Earnings Call Transcript


Steris lowers annual profit forecast due to a stronger dollar

Feb 5, 2025, 6:43 PM EST - 4 months ago

Steris lowers annual profit forecast due to a stronger dollar


STERIS Announces Outcome of Ethylene Oxide Trial

Jan 21, 2025, 6:30 AM EST - 5 months ago

STERIS Announces Outcome of Ethylene Oxide Trial


Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'

Nov 17, 2024, 8:58 PM EST - 7 months ago

Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'


STERIS plc (STE) Q2 2025 Earnings Call Transcript

Nov 7, 2024, 3:50 PM EST - 8 months ago

STERIS plc (STE) Q2 2025 Earnings Call Transcript


15 Upcoming Dividend Increases Including A King

Aug 29, 2024, 4:51 PM EDT - 10 months ago

15 Upcoming Dividend Increases Including A King

BAC CHRW CTVA CWEN FOX FOXA HRB


STERIS to Present at the Morgan Stanley Healthcare Conference

Aug 26, 2024, 4:30 PM EDT - 10 months ago

STERIS to Present at the Morgan Stanley Healthcare Conference


Steris: Q2 Numbers Solidify Buy Thesis

Aug 13, 2024, 9:51 AM EDT - 11 months ago

Steris: Q2 Numbers Solidify Buy Thesis


STERIS plc (STE) Q1 2025 Earnings Call Transcript

Aug 7, 2024, 11:27 AM EDT - 11 months ago

STERIS plc (STE) Q1 2025 Earnings Call Transcript


STERIS Announces Financial Results for Fiscal 2025 First Quarter

Aug 6, 2024, 4:30 PM EDT - 11 months ago

STERIS Announces Financial Results for Fiscal 2025 First Quarter


STERIS Raises Dividend to $0.57 per share

Jul 31, 2024, 4:30 PM EDT - 11 months ago

STERIS Raises Dividend to $0.57 per share


STERIS plc (STE) Q4 2024 Earnings Call Transcript

May 9, 2024, 2:30 PM EDT - 1 year ago

STERIS plc (STE) Q4 2024 Earnings Call Transcript


STERIS Announces Dividend of $0.52 per share

May 1, 2024, 4:30 PM EDT - 1 year ago

STERIS Announces Dividend of $0.52 per share


STERIS plc (STE) Q3 2024 Earnings Call Transcript

Feb 8, 2024, 1:08 PM EST - 1 year ago

STERIS plc (STE) Q3 2024 Earnings Call Transcript


STERIS' (STE) Q2 2024 Earnings Call Transcript

Nov 8, 2023, 1:05 PM EST - 1 year ago

STERIS' (STE) Q2 2024 Earnings Call Transcript


STERIS Raises Dividend to $0.52 per share

Jul 26, 2023, 4:30 PM EDT - 2 years ago

STERIS Raises Dividend to $0.52 per share


Steris paying $540 mln for BD surgical instrument unit

Jun 20, 2023, 8:18 AM EDT - 2 years ago

Steris paying $540 mln for BD surgical instrument unit

BDX


BD to Sell Surgical Instrumentation Platform to STERIS

Jun 20, 2023, 8:01 AM EDT - 2 years ago

BD to Sell Surgical Instrumentation Platform to STERIS

BDX


NoOnions
NoOnions Jun. 23 at 6:40 PM
$TOMZ Whats funnier? ray getting stung by a bee or Iran being turned into a parking lot? BZZZZZZ, Kaboom. Lets have a win-win deal. Pour honey all over Ayatollahs nuts and the bees Steramist saves can sting him to death.And Ray makes big money. $STE $PFE $JNJ $LLY Wake up people. Steramist can save the world.Buyout coming from a big boy.
0 · Reply
DonCorleone77
DonCorleone77 Jun. 21 at 1:45 PM
$STE Steris awarded $450M Navy contract modification Steris has been awarded a maximum $450M modification exercising the five-year option period of a five-year base contract with one five-year option period for patient monitoring and capital equipment. This is a fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity contract. The ordering period end date is June 22, 2030. Using customers are Army, Navy, Air Force, Marines Corps, and federal civilian agencies. Type of appropriation is fiscal 2025 through 2030 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support.
0 · Reply
NoOnions
NoOnions Jun. 10 at 11:25 AM
$MMM $STE I wonder if Steramist would be a good fit in your arsenal? $TOMZ is in buyout territory. Trump should be spraying this shit all over LA. RFK sprays Steramist on his wife before he knocks that out.Dont sell until you see the $3/Sh number is what WrongRay says!
0 · Reply
d_risk
d_risk May. 30 at 12:53 AM
$STE - STERIS plc (Ireland) Ordinary Shares - 10K - Updated Risk Factors STE’s 2025 10-K risks highlight intensified economic, geopolitical, and regulatory challenges, expanded healthcare policy and reimbursement uncertainties, heightened EO sterilization litigation and regulatory scrutiny, supply chain vulnerabilities, competitive pressures, acquisition integration risks, rising compliance costs, and potential goodwill impairments—all threatening financial flexibility and operational stability. #HealthcareSector #EconomicChallenges #LitigationRisks #SupplyChain #RegulatoryRisks 🟢 Added 🟠 Removed https://d-risk.ai/STE/10-K/2025-05-29
0 · Reply
JarvisFlow
JarvisFlow May. 29 at 12:30 PM
Jefferies has updated their rating for Steris ( $STE ) to Hold with a price target of 263.
0 · Reply
CHItraders
CHItraders May. 29 at 11:14 AM
📈 INITIATIONS $ELS Equal-Weight Barclays $70 $HPQ Neutral KGI Securities $25 $PRSU Buy Stifel $38 $STE Hold Jefferies $263 $IPXXU Buy Roth Capital Partners $15
0 · Reply
ZacksResearch
ZacksResearch May. 21 at 11:24 AM
$STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment. Read the full story here: https://www.zacks.com/stock/news/2475126/is-it-the-right-time-to-hold-steris-stock-in-your-portfolio?cid=sm-stocktwits-2-2475126-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2475126_TEASER
0 · Reply
NoOnions
NoOnions May. 16 at 11:09 AM
$TOMZ Asshat thinks he knows more than institutional buyers. Stop smoking crack Ray. RFK says its bad for your health. https://fintel.io/so/us/tomz Only a matter of time before large fish scoops up this little nugget. $TSLA Even Elon sprays Steramist on his rockets ! $NVDA $STE
0 · Reply
kylehardy15
kylehardy15 May. 15 at 2:11 PM
$LUCD $BSX $MDT $STE $LH STERIS purchased truFreeze a few years back which treats esophageal cancer.
2 · Reply
Estimize
Estimize May. 15 at 10:03 AM
$STE reported 2.74 EPS and 1,481 revenue for Q4. http://www.estimize.com/intro/ste?chart=historical&metric_name=eps&utm_content=STE&utm_med
0 · Reply
DonCorleone77
DonCorleone77 May. 14 at 8:41 PM
$STE Steris sees FY26 adjusted EPS $9.90-$10.15, consensus $9.88 Sees FY26 revenue up 6%-7%. The company said, "For fiscal 2026, the Company expects as reported revenue from continuing operations to increase 6-7%. Based on forward rates through March 31, 2026, currency is expected to be neutral to revenue in fiscal 2026. As a result, constant currency organic revenue growth from continuing operations is also anticipated to be 6-7%. Adjusted earnings per diluted share from continuing operations is anticipated to be in the range of $9.90 to $10.15, an increase of 7-10% compared with $9.22 in adjusted earnings per diluted share from continuing operations in fiscal 2025. Included in this outlook is the negative impact of tariffs, estimated to reduce pre-tax profit by approximately $30 million. Capital expenditures are anticipated to be approximately $375 million and free cash flow is expected to be approximately $770 million."
0 · Reply
DonCorleone77
DonCorleone77 May. 14 at 8:40 PM
$STE Steris reports Q4 adjusted EPS $2.74, consensus $2.60 Reports Q4 revenue $1.5B, consensus $1.47B. "Fiscal 2025 was another record year," said Dan Carestio, President and CEO of Steris. "We continue to benefit from our diversified Customer base and growth in global procedure volumes. We appreciate the efforts of our global Associates who continue to put Customers first. We look forward to another successful year in fiscal 2026."
0 · Reply
Estimize
Estimize May. 13 at 8:00 PM
Wall St is expecting 2.29 EPS for $STE Q1 [Reporting 08/11 AMC] http://www.estimize.com/intro/ste?chart=historical&metric_name=eps&utm_cont
0 · Reply
ChessGM
ChessGM May. 8 at 8:27 PM
$STE Heads up alert! Upcoming earnings on Wednesday, 5/14/2025 for $STE Bullish (7.5) In the recent analysis of STERIS plc (NYSE: STE), key financial metrics indicate a positive outlook for the company. The announced quarterly dividend of $0.57 per share reflects STERIS's commitment to returning value to shareholders, which is a crucial indicator of financial stability and confidence in future earnings. The company has observed a share price increase of 6% over the past month, likely driven by this dividend announcement and overall market conditions. Financially, STERIS is positioned well within the surgical equipment and consumables industry, where it has consistently reported strong performance metrics. The company’s price-to-earnings (P/E) ratio currently stands at 28, which, while slightly above the industry average of 25, suggests that investors are willing to pay a premium for anticipated growth. Furthermore, the expected earnings per share (EPS) growth rate of approximately 8% for the next fiscal year aligns with market expectations, positioning STERIS favorably compared to its peers, such as Hologic and Zimmer Biomet, both of which have faced headwinds recently. Revenue forecasts also point to a robust pipeline in bioprocessing demand, indicating a strong rebound potential that could further bolster STERIS's market position. In terms of the upcoming earnings report, STERIS is scheduled to release its fiscal 2025 fourth quarter and full year financial results on May 15, 2025. Analyst consensus estimates are optimistic, projecting a revenue increase driven by the recovery in the Applied Sterilization Technologies (AST) segment. Historical performance suggests that STERIS has successfully met or exceeded earnings estimates in recent quarters, which could lead to a positive market reaction if this trend continues. Investors will be keen to observe management's commentary on growth strategies and market conditions, especially in light of industry challenges such as inventory destocking. The anticipated results and insights from the upcoming conference call will be critical in shaping investor sentiment and could potentially reinforce the stock's bullish trajectory. - Funds were net buyers of $STE during the previous reporting quarter. - Top 5 funds with large holdings in $STE: * Generation Investment Management LLP $655MM. CGMFundRank: 58%, Fund Website: www.generationim.com * Select Equity Group LP $534MM. CGMFundRank: 77%, Fund Website: www.selectequity.com * GW&K Investment Management LLC $37MM. CGMFundRank: 80% * Balyasny Asset Management LLC $24MM. New position. CGMFundRank: 91%, Fund Website: www.bamfunds.com * Adage Capital P $9MM. CGMFundRank: 72%, Fund Website: www.adagecapital.com - Last 10 days performance: 0% - Last 30 days performance: 8% - Last 90 days performance: 1% Follow ChessGM on stocktwits.com to get timely earnings alerts. Not a financial advice. Not a trading signal.
0 · Reply
xx007xx
xx007xx May. 2 at 10:56 AM
$LUCD $BSX $MDT $STE $LH Yeah, I guess none of these organizations have any form of interest in the esophageal disease space. But what do I know? Just a quick google search of diagnostic & therapeutics for the esophagus. 🙈😉🙄
1 · Reply
DividendPower
DividendPower Apr. 30 at 7:21 PM
The 2025 Dividend Contenders: A Complete List and Financial Insights - Updated 04/30/25 https://www.dividendpower.org/2025-dividend-contenders/ $AES $WSO $UFPI $STE $OTEX
0 · Reply
Estimize
Estimize Apr. 30 at 12:54 PM
Wall St is expecting 2.60 EPS for $STE Q4 [Reporting 05/14 AMC] http://www.estimize.com/intro/ste?chart=historical&metric_name=eps&utm_cont
0 · Reply
JarvisFlow
JarvisFlow Apr. 10 at 1:52 PM
JMP Securities has adjusted their stance on Steris ( $STE ), setting the rating to Market Outperform with a target price of 265.
0 · Reply
JarvisFlow
JarvisFlow Apr. 7 at 5:14 PM
Needham updates rating for Steris ( $STE ) to Hold.
0 · Reply
swingingtech
swingingtech Mar. 24 at 7:00 PM
$STE $AHCO $DOWI https://wallstreetwaves.com/analyzing-steris-stock-performance-in-comparison-to-the-dow-is-it-underperforming/
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 22 at 11:14 PM
$STE Digging the infection prevention play. Healthcare segment looking strong with consistent growth. AST segment positioning looks solid for long-term. Might add to my portfolio on next dip. Margins expanding and global presence gives nice diversification. great article: https://beyondspx.com/article/steris-plc-a-resilient-provider-of-infection-prevention-solutions-amidst-evolving-healthcare-dynamics
0 · Reply
swingingtech
swingingtech Mar. 12 at 1:26 PM
$DXCM $DOWI $STE https://wallstreetwaves.com/analyzing-dexcom-stock-performance-compared-to-the-dow-jones-index/
0 · Reply